BPM – DNlite against Diabetes Kidney Failure

With 8,5% of the global population suffering from Diabetes, also kidney damage caused by diabetes is on the rise. The great advantage of the DNlite test offered by BPM is that Diabetic Nephropathy (Kidney Failure) can be detected 5-10 years earlier. This innovative diagnosis tool, a non-invasive urinary test, is also ideal for monitoring the progression and severity of Diabetic Nephropathy. Thanks to the efforts of BPM Kidney Failure caused by diabetes can be managed much better and the quality of life improved.

BPM is a clinical-staged biotech company, focusing on developing novel biomarker-based diagnostics for chronic diseases and oncology. BPM was spun off ITRI in 2014 to make core technologies from the National Biomarker Project available for the global healthcare community.

Interested to work with this company? >> LET US KNOW

>> MORE INFO

Comments are closed.

Contact Details

Taipei Office
Taipei CoSpace, 2F, No. 12, Zhouzi Street, Neihu District, Taipei City, Taiwan 114
Tiger Accelerator
Contact: Edda Chang & Vivian Wang
Email: service@taiwanglobalization.net
Telephone: +886 968-022-668 & +886 975-657-586

Netherlands Office
Jaarbeurs Innovation Mile (JIM)
Jaarbeursplein 6, 3521 AL Utrecht, The Netherlands
Contact : Valerie Hsu
Telephone: +31610894908 Email: TGN@taiwanglobalization.net

Disclaimer

Copyright applies only for page content not for posts




serviced by Bokxing IT
secure & sustainable hosting by 1A First Alternative
powered by Pioneerz